Verhofstede 1999.
| Methods | N=9 Non randomized FUP=unclear W/o d/o: unreported | |
| Participants | Eligibility:‐ NRTI regimen, VL (15,924‐997.361) copies/ml, | |
| Interventions | TI unclear duration | |
| Outcomes | VL rebound: 77% participants Loss of mutations: 88% participants | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Allocation concealment? | Unclear risk | D ‐ Not used |